Latest News about RBGPF
Recent news which mentions RBGPF
FDA Wants To Pull Popular OTC Decongestant Used For Common Cold Over Effectiveness Concerns
November 08, 2024
From Benzinga
Consumer Giant Reckitt Seeks Help From Investment Banks To Evaluate Options For Homecare Brands, Baby Formula
September 18, 2024
From Benzinga
From Benzinga
What's Going On With Abbott Laboratories Stock On Friday?
March 15, 2024
From Benzinga
Durex Owner Reckitt Benckiser Taps Into China's Livestreaming Trend To Sell Condoms Online
February 29, 2024
From Benzinga
FDA Panel Says Popular OTC Cold, Allergy Medicine Might Be Useless - Stocks To Watch
September 12, 2023
From Benzinga
Is There Collusion in the Baby-Formula Industry?: FTC Scrutinizes State Contracts Bidding Process
May 24, 2023
From Benzinga
From MarketWatch
Reckitt Sees US Baby Food Formula Crisis Persisting Till Spring: Report
December 02, 2022
From Benzinga
‘If the FDA is expected to do more, it needs more’: FDA investigation into baby-formula crisis points to its own shortcomings. But shortages persist.
September 23, 2022
From MarketWatch
British Consumer Company Reckitt Benckiser's CEO Steps Down
September 01, 2022
From Benzinga
Baby formula shortage is finally easing, although some states are still seeing high out-of-stock rates
August 18, 2022
From MarketWatch
From Benzinga
From Benzinga
From MarketWatch
From MarketWatch
Department of Agriculture offers to help states access more baby-formula brands for low-income families
May 26, 2022
From MarketWatch
From Benzinga
From Benzinga
From MarketWatch
From Benzinga
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free